The KgA1c Paradox: Widening the spectrum

Area of Science:

• Endocrinology and Metabolism
• Diabetes Mellitus Research
• Clinical Pharmacology

Background:

• The HbA1c paradox refers to unexplained weight gain in patients with diabetes undergoing conventional therapy.
• This phenomenon complicates diabetes management and impacts patient health outcomes.

Purpose of the Study:

• To explore the multifaceted aspects of the HbA1c paradox, including its pathophysiology, prevention, and pharmacological interventions.
• To introduce a novel index for evaluating metabolic control and drug efficacy in diabetes.

Main Methods:

• Review of existing literature on the pathophysiology, epidemiology, and management of the HbA1c paradox.
• Proposal of a new index: HbA1c product (Body Mass Index x HbA1c).

Main Results:

• The HbA1c paradox is influenced by various factors including pathophysiology, pharmacology, and person-centered care.
• The proposed HbA1c product index offers a potential tool for assessing metabolic control and drug effectiveness.

Conclusions:

• Understanding the HbA1c paradox is crucial for optimizing diabetes treatment strategies.
• The HbA1c product may serve as a valuable metric in clinical practice for managing diabetes and evaluating therapeutic interventions.